Results 51 to 60 of about 129,498 (304)
Post-COVID-19 Kawasaki-Like Vasculitis and Endocarditis: A Case Report
Panorama of Emergency MedicineBackground: Coronavirus Disease of 2019 (COVID-19) can cause mild to severe infection, but with a combination of inflammatory complications that target virtually anywhere in the body.
Hilal Abdessamad +7 more
doaj +1 more source
NUEVOS HORIZONTES EN EL TRATAMIENTO DE LA ENFERMEDAD DE KAWASAKI
Biociencias, 2019 La enfermedad de Kawasaki, es una vasculitis auto limitada que afecta principalmente a niños pequeños; Es la segunda causa más común de vasculitis en menores de 5 años.
Cristina Muñoz Otero
doaj +1 more source
The etiologies of Kawasaki disease
Journal of Clinical InvestigationKawasaki disease (KD) is a systemic vasculitis that affects young children and can result in coronary artery aneurysms. The etiology is currently unknown, but new clues from the epidemiology of KD in Japan, the country of highest incidence, are beginning
Jane C. Burns
semanticscholar +1 more source
The up‐to‐date pathophysiology of Kawasaki disease
Clinical & Translational Immunology, 2021 Kawasaki disease (KD) is an acute systemic vasculitis of an unknown aetiology. A small proportion of children exposed to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) or infected by Yersinia reproducibly develop principal symptoms of KD in
T. Hara, Kenichiro Yamamura, Y. Sakai
semanticscholar +1 more source
Progress in functional mechanisms and biomarkers of miRNA related to Kawasaki disease
Shanghai Jiaotong Daxue xuebao. Yixue ban, 2023 Kawasaki disease is an acute febrile exanthema pediatric disease with systemic vasculitis as the main lesion, which is the most common cause of acquired heart disease in children.
FENG Jiali, PENG Yu, DUAN Junkai
doaj +1 more source
Clinical Infectious Diseases, 1999 KS is a fascinating illness of childhood that has emerged over the last 30 years and is now recognized as the most common cause of acquired heart disease in children in the United States. It has a dramatic clinical presentation in most cases, but for a small number of cases that present with a more subtle disease there appears to be a greater risk of ...
W H, Mason, M, Takahashi
openaire +2 more sources
Kawasaki Disease and Coronary Artery Involvement: A Narrative Review
Cureus, 2022 Kawasaki disease is a systemic vasculitis with a risk of developing coronary artery lesions if left untreated. Kawasaki disease can be diagnosed clinically with classical symptoms (conjunctivitis, rash, lymphadenopathy, mucositis, edema of hands and feet)
K. Rajasekaran +4 more
semanticscholar +1 more source
Current Opinion in Rheumatology, 1990 Kawasaki disease is an acute vasculitis of young children that is complicated by the development of myocarditis and coronary artery abnormalities. Recent studies indicate that the prevalence of cardiovascular abnormalities can be significantly reduced by treating patients during the first 10 days of illness with high-dose intravenous gammaglobulin ...
R, Sundel, D Y, Leung
openaire +4 more sources
Kawasaki disease or Kawasaki syndrome? [PDF]
Annals of the Rheumatic Diseases, 2020 In the first months of COVID-19 pandemic, paediatricians were not much involved in the management of the illness. Reports from China had shown that relatively few children and adolescents were affected, and that most of those who were infected had experienced milder disease compared with adults.1 2 The same trend was initially seen after the spread of ...
Ravelli A. +3 more
openaire +2 more sources
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Introduction This study investigated the safety and efficacy of single‐needle Rheocarna therapy for chronic limb‐threatening ischemia (CLTI) with wounds. Methods Six patients with CLTI involving ulcers unresponsive to revascularization underwent single‐needle Rheocarna treatment.
Yasutaka Yamauchi +9 more
wiley +1 more source